Skip to Content

Manzo Pharmaceuticals Inc MNZO

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Manzo Pharmaceuticals Inc manufactures and sells products and owns patents in the field of supplemental and holistic cures sold through retail and online distribution. The company also develops its lactose intolerance product, in which it holds an exclusive patent license. Its primary products are dietary supplements, probiotics and natural remedies. In addition tit also owns other products, including a remedy for babies suffering from colic and/or digestive gas. Geographically, operation of the group is functioned through United States.

385 Whitcomb Boulevard, Gerasimos Morfesis
Tarpon Springs, FL, 34689
T +1 727 202-9887
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Sep 30, 2005
Fiscal Year End Dec 31, 2015
Stock Type Hard Assets